Cargando…

Reply: K-Ras: a prognostic factor for survival in non-small cell lung cancer

Detalles Bibliográficos
Autor principal:	Mascaux, C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361291/ http://dx.doi.org/10.1038/sj.bjc.6603113

Ejemplares similares

Ras oncogene mutations and survival in patients with lung cancer
por: Ferretti, G, et al.
Publicado: (2006)

Reply to: Comment on ‘Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung’
por: Robinson, Lary A, et al.
Publicado: (2017)

Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
por: Satoh, Hiroaki, et al.
Publicado: (2022)

K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value
por: D'Arcangelo, Manolo, et al.
Publicado: (2012)

p53 and angiogenesis in non-small-cell lung cancer: Reply to the letter from Giatromanolaki and Koukourakis
por: Fontanini, G
Publicado: (1998)

Prognostic factors in gastric carcinoma - reply
por: Setälä, Leena, et al.
Publicado: (1997)

Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma
por: Khurana, Sahil, et al.
Publicado: (2023)

Factors affecting long‐term survival of non‐small‐cell lung cancer patients with concomitant type 2 diabetes mellitus
por: Jiang, Ju‐Ying, et al.
Publicado: (2022)

Reply to K. Takada et al.
por: Ballman, Madison, et al.
Publicado: (2021)

Immunomodulatory effects of chemotherapy on blood lymphocytes and survival of patients with advanced non-small cell lung cancer
por: Aldarouish, Mohanad, et al.
Publicado: (2019)

Reply to: “Ductular reaction is a prognostic factor in primary biliary cholangitis”
por: Carpino, Guido, et al.
Publicado: (2023)

Reply: Comment on ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colo-rectal cancer'
por: Renaud, Stéphane, et al.
Publicado: (2015)

K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer.
por: Fukuyama, Y., et al.
Publicado: (1997)

Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply
por: Xu, Song-Tao, et al.
Publicado: (2020)

Reply: Patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small-cell lung cancer
por: Belderbos, J, et al.
Publicado: (2007)

The Authors reply: Comment on: “Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy” by Burtin et al.
por: Burtin, Chris, et al.
Publicado: (2021)

Reply: Imaging-Based Obesity Assessment for Risk Factor Stratification and Prognostication in Malignancy
por: Liu, Elizabeth E., et al.
Publicado: (2022)

Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer
por: Asahina, H, et al.
Publicado: (2007)

Merkel cell polyomavirus and non-small cell lung cancer
por: Shuda, M, et al.
Publicado: (2013)

Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non‐small cell lung cancer
por: Lin, Zhihuan, et al.
Publicado: (2020)

Reply: Prostate Cancer and Cardiovascular Risk Factors
por: Klimis, Harry, et al.
Publicado: (2023)

In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023)

Relationship between obstructive lung disease and non-small cell lung cancer
por: Akamine, Takaki, et al.
Publicado: (2020)

Response to cytotoxic chemotherapy and overall survival in non-small cell lung cancer patients with positive or negative ERCC1 expression
por: Honma, Helen Naemi, et al.
Publicado: (2018)

Comment on ‘Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung’
por: Ponzetto, Antonio, et al.
Publicado: (2017)

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
por: Jin, Hua, et al.
Publicado: (2019)

Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers
por: Cekani, Elona, et al.
Publicado: (2022)

miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients
por: Rodríguez-Antolín, Carlos, et al.
Publicado: (2019)

Reply on "Characteristics and Survival of Korean Anal Cancer From the Korea Central Cancer Registry Data"
por: Park, Hyoung-Chul, et al.
Publicado: (2014)

Reply: Thymidylate synthase polymorphism and survival of colorectal cancer patients treated with 5-fluorouracil
por: Iacopetta, B, et al.
Publicado: (2002)

Reply: A morpho-molecular prognostic model for hepatocellular carcinoma
por: Srivastava, S, et al.
Publicado: (2013)

Reply to: Prognostic implications of vitamin D in patients with COVID-19
por: Hastie, Claire E., et al.
Publicado: (2020)

Reply to: Improving survival from mechanical chest compression resuscitation
por: Azeli, Youcef, et al.
Publicado: (2022)

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
por: Mascaux, C, et al.
Publicado: (2005)

Reply on "Data on the Characteristics and the Survival of Korean Patients With Colorectal Cancer From the Korea Central Cancer Registry"
por: Park, Hyoung-Chul, et al.
Publicado: (2014)

Reply: Comment on ‘Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal-antibody therapy for RAS wild-type metastatic colorectal cancer'
por: Rowland, Andrew, et al.
Publicado: (2015)

Reproductive factors are crucial in the aetiology of breast cancer - a reply
por: Stewart, T H M, et al.
Publicado: (2000)

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
por: Mascaux, C, et al.
Publicado: (2006)

Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses—reply
por: Hu, Xiao, et al.
Publicado: (2020)

Genetic landscape of prognostic value in pancreas ductal adenocarcinoma microenvironment—reply
por: Pu, Ning, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_96pno8vb32ffc55dhnuvmc8j04